Latest Headlines

  1. Entellus Medical To Acquire Spirox IN $81M Deal

    Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it has entered into a definitive agreement to acquire Spirox, Inc., a privately-held ENT medical technology company that develops, manufactures and markets the LATERA™ Absorbable Nasal Implant, a minimally invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction.

  2. Cerus Endovascular’s Neurovascular Systems Earns CE Mark Approval

    Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU).

  3. Cardiologs’ AI-Powered ECG Analysis Platform Cleared By FDA

    Cardiologs Technologies SAS announced recently that it has received FDA clearance of its Cardiologs ECG Analysis Platform, a cloud-based cardiac monitoring-analysis web service powered by artificial intelligence (AI).

  4. Edwards' INSPIRIS RESILIA Valve Receives FDA Approval

    Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, recently announced it received U.S. Food and Drug Administration (FDA) approval for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves.

  5. Roche Acquires Diabetes App Maker mySugr

    Roche and mySugr announced recently that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche’s new patient-centered digital health services platform in diabetes care.

  6. Philips Healthcare Acquires CardioProlific

    Royal Philips, a global leader in health technology, recently announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed.

  7. Varian’s Image-Guided Radiotherapy Systems Earns FDA Clearance

    Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its Halcyon™ system, its new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT).

  8. MKS Announces Ophir® BeamSquared™ 2.0, Laser Beam Propagation System for Continuous Use Applications

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, announces Ophir® BeamSquared™ 2.0, the newest version of the company's M2 laser beam propagation system designed to help users optimize laser performance. A robust, portable device, BeamSquared automatically measures the propagation characteristics of CW and pulsed lasers quickly, in less than one minute.

  9. Philips To Acquire Spectranetics Corp. For €1.9B

    Royal Philips, a global leader in health technology, and The Spectranetics Corporatio, a U.S.-based global leader in vascular intervention and lead management solutions, recently announced that they have entered into a definitive merger agreement.

  10. Zimmer Biomet Launches First X-Ray-Based, Patient-Specific Instrument System For Total Knee Replacement

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today introduced its X-ray-based Patient Specific Instrument, X-PSI™ Knee System, which is the world's first CE Marked surgical planning system that allows for patient specific implant positioning solely utilizing X-ray technology.